TW200811094A - Process and novel intermediates for the preparation of 3,3'-dihydroxyisorenieratine - Google Patents

Process and novel intermediates for the preparation of 3,3'-dihydroxyisorenieratine Download PDF

Info

Publication number
TW200811094A
TW200811094A TW96124528A TW96124528A TW200811094A TW 200811094 A TW200811094 A TW 200811094A TW 96124528 A TW96124528 A TW 96124528A TW 96124528 A TW96124528 A TW 96124528A TW 200811094 A TW200811094 A TW 200811094A
Authority
TW
Taiwan
Prior art keywords
formula
alcohol
ketone
acid
doc
Prior art date
Application number
TW96124528A
Other languages
Chinese (zh)
Inventor
Hansgeorg Ernst
Klaus Henrich
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of TW200811094A publication Critical patent/TW200811094A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • C07C39/373Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C49/245Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
    • C07C49/248Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5442Aromatic phosphonium compounds (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to an improved process for the preparation of 3,3'-dihydroxyisorenieratine of formula I and to novel intermediates of this process.

Description

200811094 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種製備式k3,3,_二窥基異瑞尼爾瑞廷 PJ’-chhydroxyisorenieratin,此後稱為 φ,φ 胡蘿蔔素 二醇)之改良方法且係關於該方法之新穎中間物。200811094 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to a preparation of the formula k3,3,_ bisphthyl ruthenium ruthenium PJ'-chhydroxyisorenieratin, hereinafter referred to as φ, φ carotenoid diol) The improved method is a novel intermediate with respect to the method.

【先前技術】 式I之3,3匕二备基異瑞尼爾瑞廷(φ,φ_胡蘿蔔素」^匕二 醇)作為飼料添加劑受到極大關注(br〇iler skin pigmentation: Riv. Zootec. Vet. 1974, 15 31^44; egg yolk pigmentation: Z. Allg· Mikrobiol· (1970),10(4),237_244)。 文獻中描述由醱酵作用製備φ,φ_胡蘿蔔素_3,3l二醇之 不同安排。該等方法通常具有極低空間/時間產率。另 外,分離純的式I之顏料需要極昂貴之純化操作,故不易 容許工業上經濟之實施(J. Ind· Msicrobiol. Biotechnol. 24, 1,64-70 (2000) ; Riv. Zootec· Vet· 1974,1,31-44 ; Phytochemistry 22, 11,207-210, 1983)。因此,總體化學合 成為製備純的式I之Φ,Φ-胡蘿蔔素-3,3,-二醇之較佳途徑。 DE 1593440描述式I之φ5φ-胡蘿_素_3,3,_二醇之合成。[Prior Art] 3, 3, 2, 2, 2, 2, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4 Vet. 1974, 15 31^44; egg yolk pigmentation: Z. Allg· Mikrobiol· (1970), 10(4), 237_244). Different arrangements for the preparation of φ, φ_carotene _3, 3l diol by fermentation are described in the literature. These methods typically have very low space/time yields. In addition, the separation of pure pigments of formula I requires extremely expensive purification operations and is therefore difficult to tolerate industrially economical implementation (J. Ind. Msicrobiol. Biotechnol. 24, 1, 64-70 (2000); Riv. Zootec Vet. 1974, 1, 31-44; Phytochemistry 22, 11, 207-210, 1983). Therefore, the overall chemical combination is a preferred route for the preparation of pure Φ, Φ-carotene-3,3,-diol of formula I. DE 1593440 describes the synthesis of φ5φ-carotenoid-3,3,_diol of formula I.

在該合成之最後階段中,如以下反應流程所示,根據 C10+C2G+C1()合成策略使藏花酸二醛1與兩當量鱗鹽2在雙維 蒂希烯化反應(double Wittig olefination)中反應以產生式I 121668.doc 200811094 之Φ,Φ «胡蘿蔔素· 3,3 ’ -二醇。In the final stage of the synthesis, as shown in the following reaction scheme, crocetin dialdehyde 1 and two equivalents of scale salt 2 are subjected to double Wittig olefination according to the C10+C2G+C1() synthesis strategy. The reaction is carried out to produce Φ, Φ «carotene 3,3 '-diol of formula I 121668.doc 200811094.

根據 DE 1593440,實例 2,由 2·5 8 g(8.72 mmol)< i 之二 酸在消去保護基後僅獲得1.5 g式I之Φ,Φ-胡蘿蔔素」,=According to DE 1593440, Example 2, only 2. 5 g of Φ, Φ-carotene of formula I is obtained after elimination of the protecting group from 2·5 8 g (8.72 mmol) of diacid.

醇(2.68 mm〇1=理論值之30.7〇/〇)。對工業方法而言,該產率 太低。 該合成所需之式2之鱗鹽係由式II之2,3,6-三甲基-4-經基 苯甲·以四階段序列法製備。根據DE-1593440,實例i, 由 14·6 g(89.02 mmol)式 II之醛僅獲得 6·4 g(11.13 mmol)式 2 之鑌鹽。該產率亦不令人滿意。Alcohol (2.68 mm 〇 1 = 30.7 〇 / 理论 of theory). For industrial processes, the yield is too low. The scale salt of formula 2 required for this synthesis is prepared from the 2,3,6-trimethyl-4-perbenzylbenzene of formula II in a four-stage sequence. According to DE-1593440, Example i, only 14.4 g (11.13 mmol) of the phosphonium salt of the formula 2 is obtained from 14·6 g (89.02 mmol) of the aldehyde of the formula II. This yield is also unsatisfactory.

EP 882 709描述按照以下合成策略合成玉米黃素:EP 882 709 describes the synthesis of zeaxanthin according to the following synthetic strategy:

R=四氫哌喃基保護基R = tetrahydropyranyl protecting group

Ci〇 + C3 + C2==:Ci5 > C 1 5 + C 1 〇 + C 】5 = C 4 〇 〇 該策略在類胡蘿蔔素合成中為已知的(參看,尤其, nCar〇ten〇ldS,第 2 卷:Synthesis",第 192 頁,Birkhauser Verlag 1996,同前 92 等)。 【發明内容】 121668.doc 200811094 本發明之目標在於開發一種由已知sniCi〇結構單元製 備式I之φ,φ_,蘿蔔素-3,3,-二醇之工業上及經濟上適用的 新穎方法。另一目標在於提供製備式工之φ,φ_胡蘿蔔 素二醇之新穎方法的新穎中間物。 該目標係由製備式I之3,3,-二羥基異瑞尼爾瑞廷之方法 實現:Ci〇+ C3 + C2==:Ci5 > C 1 5 + C 1 〇+ C 】5 = C 4 〇〇 This strategy is known in carotenoid synthesis (see, in particular, nCar〇ten〇ldS) , Volume 2: Synthesis", page 192, Birkhauser Verlag 1996, ibid. 92, etc.). SUMMARY OF THE INVENTION 121668.doc 200811094 The object of the present invention is to develop an industrially and economically applicable novel method for preparing φ, φ_, radix-3,3,-diol of formula I from known sniCi〇 structural units. . Another object is to provide a novel intermediate for the novel process for the preparation of the formula φ, φ-carotene diol. This target is achieved by the method of preparing 3,3,-dihydroxyisoranin rutin of formula I:

該方法包含至少一個以下步驟: a)使式11之(:1()-醛:The method comprises at least one of the following steps: a) making (1:)-aldehyde of formula 11:

與代表式Ilia之結構單元之等效物的化合物反應:Reaction with a compound representing the equivalent of the structural unit of formula Ilia:

其置換式II之C1(r醛之羰基氧原子以產生式IViCi3__ :It replaces C1 of formula II (the carbonyl oxygen atom of the aldehyde to produce formula IViCi3__:

b)使式IV之Cn-S同與式Va之乙烯系化合物反應:b) reacting Cn-S of formula IV with a vinyl compound of formula Va:

Va , 121668.doc 200811094 或 使式iViCu-a同與式vb之乙炔系化合物反應: =~M1 Vb, 接著使參鍵部分氫化以產生式VI之Ci5-醇:Va, 121668.doc 200811094 or reacting the iViCu-a with an acetylene compound of the formula vb: =~M1 Vb, followed by partial hydrogenation of the bond to give the Ci5-alcohol of formula VI:

I OHI OH

其中 M1 為 Li、Na、K、MgCl、MgBr、Mgl 或 Mg1/2, c)使式乂1之醇與強有機或無機酸Ηχ(χ為酸HX之陰 離子)反應以產生式VII之C15結構單元:Wherein M1 is Li, Na, K, MgCl, MgBr, Mgl or Mg1/2, c) reacting an alcohol of the formula 与1 with a strong organic or inorganic hydrazine (an anion of the acid HX) to produce a C15 structure of the formula VII unit:

接著使式VII之C15結 產生式VIII2C15_鱗鹽: 15結構單元與三芳基膦P(芳基)3反應以The C15 of formula VII is then reacted to yield a VIII2C15-scale salt: 15 structural unit is reacted with a triarylphosphine P(aryl)3 to

或 芳基膦/HX加合物 曱基辛-2,4,6-三稀 使式VltCw醇與式P(芳基)3.Ηχ之 反應以產生式VIII之Ci5-鱗鹽, d)使式VIII之Cw鱗鹽與式Ιχ之2,7_ 121668.doc 200811094 二酸(2,7-(!]11161:113^1〇(^-2,4,6-1:1^1^(1131)反應: ιχ , 以產生式I之化合物。 較佳地,在製備Φ,Φ-胡蘿蔔素-3,3,-二醇之本發明之方 法中,至少執行步驟c)及d),且尤其執行步驟a)、b)、c)及 d) 〇 在本發明之方法之步驟a)中,使式11之(31()-醛與代表式 Ilia之結構單元之等效物的化合物反應以產生式Iv之Ci3_ 酮,有可能使用(例如)以下物質作為代表式IIIai結構單 兀之等效物的化合物:丙酮、2-側氧基丙基膦酸二_(31-(::1()_ 烷基酯(諸如,2-側氧基丙基膦酸二乙酯)或ι_(三芳基亞鱗 烧基)-2-丙烷(諸如三苯基亞磷烷基>2_丙烷)。 /\^° Ilia Η 式IIIa之結構單元置換式11之€1()-醛中之羰基氧原子。 較佳地,在方法步驟勾中,式^之^❶-醛在無需引入酚 性〇H基之保護基之情況下即可轉化為式IV之Cl3_酮。 因此代表A延伸之步驟a)原則上可根據已知說明進行, 例如藉助於與作為式IIIa之結構單元之等效物的丙酮發生 鹼催化縮合反應❶使用過量丙酮作為溶劑有利地進行該縮 合反應。合適鹼催化劑之實例為鹼金屬氫氧化物及鹼土金 121668.doc •10- 200811094 屬氫氧化物’尤其鹼金屬氫氧化物,諸如氫氧化鈉或氫氧 化卸。因此’藉由將以齡計約1〇_2〇倍莫耳量之丙嗣添加 至^。酸巾且在添加約兩倍等莫耳量之犯卵粉末後使溶液 回抓,可使式11之(:1()-醛轉化為式^之^广酮。 另一可能的本身已知之使式II之Cio-醛轉化為式IViCl3_ 酮的方法在於使式„之醛與作為式ma之結構單元之等效 物的2-側氧基丙基膦酸二乙酯反應。Or an arylphosphine/HX adduct thioglycine-2,4,6-tri-diuret to react with a formula V(aryl) 3. hydrazine to produce a Ci5-square salt of formula VIII, d) Cw scale salt of formula VIII and formula 2,7_121668.doc 200811094 Diacid (2,7-(!]11161:113^1〇(^-2,4,6-1:1^1^(1131 Reaction: ιχ to produce a compound of formula I. Preferably, in the process of the invention for the preparation of Φ, Φ-carotene-3,3,-diol, at least steps c) and d) are carried out, and in particular Performing steps a), b), c) and d) 步骤 in step a) of the process of the invention, reacting (31()-aldehyde of formula 11 with a compound representing the equivalent of the structural unit of formula Ilia To produce a Ci3_ ketone of the formula Iv, it is possible to use, for example, the following compound as an equivalent of the equivalent of the formula IIIai structure: acetone, 2-oxopropylpropylphosphonic acid bis(31-(::1( ) alkyl ester (such as diethyl 2-oxopropylpropylphosphonate) or i-(triarylsulfinyl)-2-propane (such as triphenylphosphinyl) > 2-propane /\^° Ilia 结构 The structural unit of formula IIIa replaces the carbonyl oxygen atom in the aldehyde of the formula 11 (1). Preferably, in the method In the tick, the formula 醛-aldehyde can be converted to the Cl3 ketone of the formula IV without introducing a protecting group of the phenolic hydrazine H group. Therefore, the step a) representing the extension of A can be known in principle. This is carried out, for example, by means of a base-catalyzed condensation reaction with acetone as an equivalent of the structural unit of the formula IIIa, and the condensation reaction is advantageously carried out using an excess of acetone as a solvent. Examples of suitable base catalysts are alkali metal hydroxides and alkaline earths. Gold 121668.doc •10- 200811094 is a hydroxide 'especially an alkali metal hydroxide, such as sodium hydroxide or hydroxide. Therefore, 'by the age of about 1 〇 2 〇 莫 量Adding to the acid wipe and transferring the solution back after adding about twice the molar amount of the egg powder, the (:1()-aldehyde of the formula 11 can be converted into the formula ketone. Another possibility A method known per se for converting a Cio-aldehyde of the formula II to a ketone of the formula IViCl3_ consists in reacting an aldehyde of the formula with diethyl 2-oxopropylpropylphosphonate as an equivalent of the structural unit of the formula ma.

cA〇~个 c2hso, 出於此目的’尤其合適之鹼為鹼金屬Cl々醇化物, 其鹼金屬(^<4_醇化物,諸如甲醇鈉或乙薄鈉。 較佳地,在方法步驟a)中,代表式腿之結構單元之 效物的化合物為Η三苯基亞磷烷基)_2_丙烷。 因此,使式π之Cl0_越轉化為式^Ci3_嗣之較佳實施 在於使C⑽與作為式IIIa之結構單元之等效物的卜(三 基亞魏基)-2-丙烧(C3_亞基)反應,且尤其在於將^ 與過篁如下之1_(三苯基亞麟烧基)_2_丙燒I 惰性溶劑中加熱: 丨3 PPh 較佳溶劑為甲苯且k亞基之過量為5_5() _〇/ ΜΗ) 在(例如)藉由經梦膠過渡分離出氧化三+ 基膦後,可以良好產率及高純度分離出式嗣。 I21668.doc 200811094 在本發明之方法之步驟!^中,式酮係藉由使該 酮與式Va之乙烯系化合物反應轉化為式¥1之匸15_醇:cA〇~c2hso, a suitable base for this purpose is an alkali metal Cl oxime, an alkali metal thereof (^<4_alcoholate, such as sodium methoxide or ethyl sulphate. Preferably, in the method step In a), the compound representing the effect of the structural unit of the leg is triphenylphosphinylalkyl)_2-propane. Therefore, the more preferred embodiment of converting Cl0_ of the formula π to the formula ^Ci3_嗣 is to make C(10) and the equivalent of the structural unit of the formula IIIa (trisyl-Wiki)-2-propane (C3_) Subunit) reaction, and in particular, heating and heating in an inert solvent of 1_(triphenylarylene)_2-propanone I as follows: 丨3 PPh The preferred solvent is toluene and the excess of k subunit is 5_5() _〇/ ΜΗ) After the separation of the tris-phosphine oxide by, for example, the transition of the dream gum, the oxime can be isolated in good yield and high purity. I21668.doc 200811094 In the step of the method of the present invention, a ketone is converted into an alcohol of the formula: 1 by reacting the ketone with a vinyl compound of the formula Va:

Va, 或與式Vb之乙炔系化合物反應·· 二’〜ί\4 Vb 9 且隨後使參鍵部分氫化轉化為式VI2Ci5醇,…為以、 Na、K、MgCl、MgBr、Mgl 或 Mg,/2,,尤其為 Li、Na、 MgCl或 〇 猎由使式IV之Cn-酮與式Vb之乙炔系化合物反應使文獻 中尚未描述之式1乂之Cn-酮轉化為亦未描述之式卩〗之 醇可根據原則上已知之說明進行。舉例而言,有可能藉由 乙炔鋰或乙炔鈉之1,2-加成使式…之^3—酮轉化為式VIa之 C15-醇,所謂的炔丙醇:Va, or reacting with an acetylene compound of the formula Vb···2'~ί\4 Vb 9 and subsequently hydrogenating the part of the bond to the alcohol of the formula VI2 Ci5, ..., Na, K, MgCl, MgBr, Mgl or Mg, /2, especially for Li, Na, MgCl or oxime, by reacting a Cn-ketone of the formula IV with an acetylene compound of the formula Vb to convert a Cn-ketone of the formula 1 which has not been described in the literature into a formula which is also not described The alcohol of 卩 can be carried out according to the instructions known in principle. For example, it is possible to convert a 3-keto of the formula to a C15-alcohol of the formula VIa by a 1,2-addition of lithium acetylide or sodium acetylide, a so-called propargyl alcohol:

OHOH

9 且隨後由Lindlar法使該醇部分氫化為式…之匕”醇。9 and then the alcohol is partially hydrogenated to the hydrazine alcohol of the formula by the Lindlar process.

Via 對酮之乙炔化及所形成之炔丙醇之部分氫化的詳情可見 於(例如)J· Am. Chem· S〇c· 1952, 74及 295,及 Helv. Chim· Acta 35 (1952),35及 445 中。 較佳地,式IVtCu-酮係以單步驟藉由乙烯基鋰或乙烯 基格林納試劑(vinyl Grignard reagenoiii加成轉化為式 121668.doc -12- 200811094 VI之 c15-醇。 ;、、化之較佳溶劑為液氨或開鏈或環狀鱗,且用於 乙烯化之較佳溶劑為開鏈或環狀醚。 、 較“地,在方法步驟b)中,使式IViCu-酮與乙烯基氯 化鎂反應。 、 尤其杈佳地,用乙烯基氯化鎂使式IV之Cu-酮乙烯化係 在氫夫南中進行,以式IV之酮計,格林納試劑係以2_5Details of the acetylation of ketones and partial hydrogenation of the formed propargyl alcohols can be found, for example, in J. Am. Chem. S〇c. 1952, 74 and 295, and Helv. Chim· Acta 35 (1952), 35 and 445. Preferably, the IVtCu-ketone of the formula IV is converted to the c15-alcohol of the formula 121668.doc -12- 200811094 VI by a vinyllithium or vinyline reagent (vinyl Grignard reagenoiii addition) in a single step. Preferred solvents are liquid ammonia or open-chain or ring-shaped scales, and preferred solvents for the alkylation are open-chain or cyclic ethers. More preferably, in the method step b, the formula IViCu-ketone is ethylene. Reaction of magnesium chloride based, particularly preferably, the vinylation of Cu-ketone of formula IV with vinyl magnesium chloride is carried out in hydrogenfon, based on the ketone of formula IV, the Grignard reagent is 2-5

莫耳^畺較彳土3_4莫耳當量之過量使用。酮之乙烯化之 詳情描述於(例如)Bull· s〇c Chem· Japan 37,(1964),2〇7 中。 在本發明之方法之步驟幻中,使式VI2Ci5_醇與強有機 或無機酸HX反應(X為酸只又之陰離子)以產生式νπ之〇15結 構單元: 11 I Λ HO 人〆\ VII , 且隨後使式VII之C〗5結構單元與三芳基膦P(芳基)3反應以 產生式Villi c15-鎸鹽:Moer is more than 3*4 molar equivalent of bauxite. Details of the ketene ethylation are described, for example, in Bull·s〇c Chem. Japan 37, (1964), 2〇7. In the step of the method of the invention, the alcohol of formula VI2Ci5_ is reacted with a strong organic or inorganic acid HX (X is an acid only anion) to produce a ν15 structural unit of the formula νπ: 11 I Λ HO 〆 VII And then reacting the C _ 5 structural unit of formula VII with the triaryl phosphine P(aryl) 3 to yield the formula Villi c15- sulfonium salt:

或使式VI2 Cm-醇用可以分離形式或以強有機或無機酸HX 與二方麟P(方基)3之混合物形式使用的式p(芳基)3·ηχ之三 121668.doc 200811094 芳基膦/HX加合物直接轉化為式VIII之Cl5_鱗鹽。 已知之 根據以上机程之式¥1之Cls_醇的轉化係由原則上 方法進行。 應瞭解,強有機或無機酸意謂其pKa值小於3、較佳小方 1之酸。強有機或無機酸之實例為諸如鹽酸、氫溴酸或j 碘酸之氯鹵酸’諸如甲烷磺酸、對甲苯磺酸或三氟甲烷与 酸之績酸,或諸如三氟乙酸或三氯乙酸之三自乙酸。’Or the formula VI2 Cm-alcohol can be used in the form of a separable form or a mixture of a strong organic or inorganic acid HX and a dinuclear P (square group) 3 of the formula p (aryl) 3 · η χ 3 121668.doc 200811094 fang The phosphine/HX adduct is converted directly to the Cl5_square salt of formula VIII. It is known that the conversion of Cls-alcohol according to the above formula is as follows. It should be understood that a strong organic or inorganic acid means an acid having a pKa value of less than 3, preferably a small square. Examples of strong organic or inorganic acids are chlorohalic acids such as hydrochloric acid, hydrobromic acid or j iodic acid such as methanesulfonic acid, p-toluenesulfonic acid or trifluoromethane with acid acid, or such as trifluoroacetic acid or trichloro Acetic acid trisodium acetate. ’

舉例而t ’可料如氯_、錢或三貌乙酸之強酸使 式VI之C15醇轉化為式VII之Ci5結構單元,X則為_離子、 磺酸根或三氟乙酸根,且隨後該式VII之化合物可藉由與 三芳基膦,尤其三苯基膦反應轉化為SVIII2Ci5_鱗鹽。 方法步驟c)中所使用之使式¥1之〇15_醇轉化為式vn之 Cu結構單元的強酸11义較佳為氫溴酸或鹽酸。 在三芳基膦P(芳基h中,芳基為經取代或未經取代之 C6-C1S-芳基,較佳為C0_Ci『芳基且尤其為苯基。芳基上之 取代基可為(例如)鹵素及htCi_Ci2_烷基,尤其為。<4_烷 基。方法步驟C)中所使用之三芳基膦p(芳基)3較佳為三苯 基膦。 尤其較佳地,在方法步驟c)之第一變化形式中,使SVI 之^5·醇與氫溴酸反應以產生式之Cis_溴化物,其中χ 為Br,且隨後使該式VII之化合物與三苯基膦反應以產生 式vniiCw鱗鹽,其中芳基為苯基且X為Br。 在方法步驟c)之第二變化形式中,根據原則上已知之說 明(參見,例如,j· 〇rg. Chem. 47 (1982),47及 2130),使 121668.doc -14- 200811094 式^之^5·醇直接與適當的式p(芳基)rHx之三芳基膦/Ηχ 加合物反應。 該反應係在-听至+机之溫度下進彳^所使用之溶劑 較佳為極性質子性溶劑,諸如二氯甲烷或二甲基甲醯胺。 可使用之式Ρ(芳基VHX之三芳基膦/ΗΧ加合物較佳為三苯 基膦氫齒酸鹽或三苯基膦硫酸氫鹽,尤其三苯基膦氫溴酸 鹽或鹽酸鹽。該反應係經由作為中間物之式¥11之心5_鹵化 物(其中Χ=Βτ或C1)進行。為分離式VIIIiCi5_鱗鹽,蒸餾 出溶劑且將產物自另一例如乙腈之合適溶劑中結晶。 方法步驟C)較佳根據第二變化形式進行,尤其用三苯基 膦氫溴酸鹽或三苯基膦鹽酸鹽(芳基為苯基且乂為仏或€1) 使式VltCn-醇直接轉化為式VIIIiCl5•鱗鹽。 在本發明方法之步驟d)中,使式VI„icl5_鎮鹽與2,'二 甲基辛-2,4,6-三烯二醛反應以產生之化合物。 文獻中先前尚未描述之式viii之Ca鱗鹽與SIX之2,7-二 曱基辛-2,4,6-三烯-1,二醛的雙維蒂希縮合反應可由該方 法之文獻中原則上已知之方法(參見,”Car〇ten〇ids,第2 卷·· Synthesis”,Birkhauser Verlag,1996)進行。用於產生 偶極體之較佳鹼為鹼金屬或鹼土金屬Ci_C6_醇鹽,較佳呈 於相應Ci-C6-醇中之溶液形式;可使用之溶劑為諸如二氯 曱烧、1,2-一氯乙烧及1,2_二氯丙烷之氯化烴,或開鏈或 環狀醚。可使用之醚性溶劑之實例為四氫呋喃、二噁烷或 乙二醇醚。亦可使用含羥基醚,諸如曱氧基丙烷醇或 2-甲氧基丙烷」_醇。與醇鹽對應之Ci_c^醇亦適合單獨或 121668.doc •15- 200811094 與以上所提及之溶劑中之一種組合用於該反應。 另一較佳實施例在於藉助於作為”潛伏鹼,,之氧玩For example, a strong acid such as chlorine, money or triacetic acid converts a C15 alcohol of formula VI to a Ci5 structural unit of formula VII, and X is an ionic, sulfonate or trifluoroacetate, and then the formula The compound of VII can be converted to the SVIII2Ci5_square salt by reaction with a triarylphosphine, especially triphenylphosphine. The strong acid 11 of the Cu structural unit of the formula vn used in the process step c) is preferably hydrobromic acid or hydrochloric acid. In the triarylphosphine P (aryl h, the aryl group is a substituted or unsubstituted C6-C1S-aryl group, preferably a C0_Ci "aryl group and especially a phenyl group. The substituent on the aryl group may be ( For example, halogen and htCi_Ci2_alkyl, especially <4_alkyl. The triarylphosphine p(aryl) 3 used in process step C) is preferably triphenylphosphine. Particularly preferably, in a first variant of process step c), the alcohol of SVI is reacted with hydrobromic acid to produce a Cis-bromide of the formula wherein χ is Br and subsequently the formula VII is The compound is reacted with triphenylphosphine to produce a quaternary salt of the formula vniiCw wherein the aryl group is phenyl and X is Br. In a second variant of method step c), according to a description known in principle (see, for example, j. 〇rg. Chem. 47 (1982), 47 and 2130), 121668.doc -14- 200811094 The alcohol is directly reacted with an appropriate triarylphosphine/ruthenium adduct of the formula p(aryl)rHx. The solvent used in the reaction at a temperature of - to + is preferably a polar protic solvent such as dichloromethane or dimethylformamide. The triarylphosphine/ruthenium adduct of the aryl VHX may preferably be triphenylphosphine hydrochloride or triphenylphosphine hydrogensulfate, especially triphenylphosphine hydrobromide or hydrochloric acid. The reaction is carried out via the core 5_halide of the formula 11 (wherein Χ=Βτ or C1) as an intermediate. To isolate the VIIIiCi5_scale salt, distill off the solvent and prepare the product from another such as acetonitrile. Crystallization in a solvent. Process step C) is preferably carried out according to a second variant, in particular with triphenylphosphine hydrobromide or triphenylphosphine hydrochloride (aryl is phenyl and hydrazine is hydrazine or €1) The VltCn-alcohol is directly converted to the VIIIiCl5•scale salt. In step d) of the process according to the invention, a compound of the formula VI „icl5_ sulphate is reacted with 2,' dimethyloctyl-2,4,6-trienedialdehyde to produce a compound which has not been previously described in the literature. The two-dimensional Tichtion condensation reaction of Ca scaly salt of viii with 2,7-dimercapto- 2,4,6-triene-1, dialdehyde of SIX can be carried out by a method known in principle in the literature of the method (see , "Car〇ten〇ids, Volume 2 · Synthesis", Birkhauser Verlag, 1996). The preferred base for the generation of the dipole is an alkali metal or alkaline earth metal Ci_C6_ alkoxide, preferably in the corresponding Ci a solution in the form of a C6-alcohol; the solvent which can be used is a chlorinated hydrocarbon such as dichlorohydrazine, 1,2-chloroethane and 1,2-dichloropropane, or an open chain or cyclic ether. Examples of the ether solvent to be used are tetrahydrofuran, dioxane or glycol ether. Hydroxy ether-containing groups such as decyloxypropanol or 2-methoxypropane-alcohol may also be used. The Ci_c^ alcohol corresponding to the alkoxide is also suitable for use in the reaction alone or in combination with one of the solvents mentioned above. Another preferred embodiment resides in the use of oxygen as a "latent base"

Ber· 107,2050等(1974))(例如)藉由在式以之― 、 v一给存在下將 式VIIHC15-鱗鹽在作為溶劑之氧呒,較 于又狂i,AJl乳丁烷中 加熱數小時產生偶極體。該反應可在純氧玩或在氧呒與以 上所提及之溶劑之一種的混合物中進行。式1之最終產物 可在此情況下藉由過濾反應混合物來分離而無需其他處理 步驟。Ber. 107, 2050, et al. (1974)), for example, by using the formula VIIHC15-salt salt in the presence of a formula, in the presence of v-, in the presence of v-oxygen, as a solvent, in the case of arsenic, AJl lactidine Heating for several hours produces a dipole. The reaction can be carried out in pure oxygen or in a mixture of oxonium and one of the solvents mentioned above. The final product of Formula 1 can be separated in this case by filtering the reaction mixture without additional processing steps.

本發明之方法打開獲得式二羥基異瑞尼爾瑞廷 (Φ,Φ-胡蘿蔔素-3,3,-二醇)之容易方法。特定言之,以下方 面令人驚舒且不能為熟習此項技術者所預知: 式II及IV之化合物中之酚性0Η基團之酸性並不干擾鹼性 介質中所發生之C3及Q延伸反應(方法步驟a)&b)), S電子且因此氧化敏感性酚並不引發氧化過程,且 在出於該目的所需之鹼性條件下,在方法步驟d)之雙維 蒂希烯化反應中並不發生三苯基膦之消去反應,即使熟習 此項技術者熟知如下事實:在產生乙烯係偶極體中鱗鹽趨 向於/肖去二苯基膦(Caroten〇ids,第2卷,第94頁)。 驗The method of the present invention opens an easy method for obtaining a dihydroxyisorane ruthine (Φ, Φ-carotene-3,3,-diol). In particular, the following aspects are surprising and are not known to those skilled in the art: The acidity of the phenolic O group in the compounds of Formulas II and IV does not interfere with the C3 and Q extensions occurring in the alkaline medium. Reaction (method step a) & b)), S-electron and thus oxidation-sensitive phenol does not initiate the oxidation process, and in the alkaline conditions required for this purpose, in the method step d) The elimination reaction of triphenylphosphine does not occur in the olefination reaction, and it is well known to those skilled in the art that in the production of ethylene-based dipoles, the scale salt tends to/di-diphenylphosphine (Caroten〇ids, 2 volumes, p. 94). Test

因此’本發明之方法藉助於以下合成策略實現開頭所陳 述之目標:Thus, the method of the present invention achieves the objectives stated at the outset by means of the following synthetic strategy:

Ci〇+C3+C2=Ci5 121668.doc -16- 200811094Ci〇+C3+C2=Ci5 121668.doc -16- 200811094

Ci5+c10+Cl产c4〇。 鋒且不能為熟習此 酚性羥基之式II之 進行,即使以上所 在本發明之情況下’以下方面令人驚 項技術者所預知:以具有未經保護之 c1(r酸起始的本發明的合成可以高產率 述之技術現狀建議該酚性羥基應受保護 本發明亦提供式IV2C131同:Ci5+c10+Cl produces c4〇. It is not possible to carry out the formula II of the phenolic hydroxyl group, even if the above is in the context of the present invention, the following aspects are known to the skilled artisan: the invention with the unprotected c1 (r acid starting) The synthesis can be described in the high yield state of the art. It is suggested that the phenolic hydroxyl group should be protected. The present invention also provides the formula IV2C131 with the same:

IV 本發明亦提供式VI之C15-醇:IV The invention also provides a C15-alcohol of formula VI:

本發明亦提供式VII之c15結構單元:The invention also provides a structural unit of formula VII:

X為強有機或無機酸HX之陰離子。X較佳為C1戍Br σ 本發明亦提供式VIII2C15-鱗鹽:X is an anion of a strong organic or inorganic acid HX. X is preferably C1戍Br σ. The invention also provides a formula VIII2C15-scale salt:

121668.doc -17- 200811094 其中 為方基基團,較佳為苯基,且X為強有機或無機酸Ηχ 之陰離子,較佳為C1或Br。芳基及X之更一般之定義對應 於方法步驟c)之詳情中所給之定義。 【實施方式】 本發明係由以下實例說明,然而不意味任何限制。121668.doc -17- 200811094 wherein is a aryl group, preferably a phenyl group, and X is an anion of a strong organic or inorganic acid hydrazine, preferably C1 or Br. The more general definition of aryl and X corresponds to the definition given in the details of method step c). [Embodiment] The present invention is illustrated by the following examples, but does not mean any limitation.

一般資訊:有機金屬化合物係在不存在空氣及水分之情 況下在惰性氣體下製備及處理。 根據 J. Indian Chem· Soc. 40, 6, 472 (1963)製備 4_ 羥基- 2,3,6-三甲基苯甲酸:。 實例1-合成式IV之C13-酮:General Information: Organometallic compounds are prepared and treated under inert gas in the absence of air and moisture. 4-Hydroxy-2,3,6-trimethylbenzoic acid was prepared according to J. Indian Chem. Soc. 40, 6, 472 (1963). Example 1 - Synthesis of C13-keto of Formula IV:

IV 將82.1 g(〇.5〇 m〇l)4-羥基_2,3,6_三甲基苯甲醛懸浮於1 ^ 甲苯中。添加175 g(〇.55 mol)l-(三苯基亞磷烷基)丙烷 且後,將混合物回流48小時。隨後,在6〇艺低至2〇毫巴 下,將反應混合物在旋轉蒸發器上濃縮。藉助於矽膠急驟 層析(溶離劑:環己烷/甲基第三丁基醚=2/1)分離出氧化三 苯基膦。將含有價值產物之溶離份組合且在+5(rc低至2〇 笔巴下在旋轉蒸發器上濃縮。為超純化,將蒸發殘餘物溶 解於熱乙腈中;將熱溶液經由凹槽型過濾器澄清且冷卻至 〇°c。將所得懸浮液在(rc下充分攪拌1小時且過濾。將濾 121668.doc -18- 200811094 餅用少量冷乙腈洗滌且在+5(TC/20毫巴了乾燥 最終重量:73.4 g(理論值之72.0%)IV 82.1 g (〇.5〇 m〇l) 4-hydroxy-2,3,6-trimethylbenzaldehyde was suspended in 1 ^ toluene. 175 g (〇.55 mol) of 1-(triphenylphosphinoalkyl)propane were added and after that, the mixture was refluxed for 48 hours. Subsequently, the reaction mixture was concentrated on a rotary evaporator at 6 liters down to 2 Torr. The triphenylphosphine oxide was isolated by means of silica gel flash chromatography (solvent: cyclohexane / methyl tert-butyl ether = 2 / 1). The fractions containing the value product are combined and concentrated on a rotary evaporator at +5 (rc as low as 2 Torr). For ultra-purification, the evaporation residue is dissolved in hot acetonitrile; the hot solution is filtered through a groove type The vessel was clarified and cooled to 〇 ° C. The resulting suspension was stirred well (rc) for 1 hour and filtered. The filter 121668.doc -18- 200811094 cake was washed with a small amount of cold acetonitrile and at +5 (TC/20 mbar) Dry final weight: 73.4 g (72.0% of theory)

Μ.ρ. : 106-1〇7〇C HPLC純度:97.9% 實例2-合成式VI之C15-醇Μ.ρ. : 106-1〇7〇C HPLC purity: 97.9% Example 2 - Synthesis of C15-alcohol of formula VI

將51·〇 g(0.25 mol)來自實例1之式IViCi3-酮溶解! 四氫呋喃中。在0它下,經i小時逐滴添加833…乙烯基氯 化鎂於四氫呋喃中之L2莫耳濃度溶液@1〇 m〇i格林納試 劑(Grignard reagent))且接著在吖下將混合物攪拌丨小時。 就處理而言,在〇至+5t:下,經3〇分鐘,將混合物逐滴 添加至2 1半飽和氯化銨水溶液中。隨後,在充分攪拌下, 注入2 1甲基第三丁基醚。分離出下層水相且用5〇〇 mi甲基 第二丁基醚再萃取兩次。將組合之有機相用i丨半飽和氯化 鉍溶液洗滌1次且用水洗滌〗次,經硫酸鈉乾燥且在+5〇它 低至20宅巴下在旋轉蒸發器上濃縮。將蒸發殘餘物隨後在 + 50C低至5毫巴下乾燥〗小時以產生671 g HpLC分析純度 為84·7%之黃色固體殘餘物。其對應於理論值之98%之產 率° 該粗產物無需進一步純化即可處理。 貫例3-合成式乂111-&之(^15-鱗鹽: 121668.doc -19- 20081109451·〇 g (0.25 mol) of the IViCi3-one from Example 1 was dissolved in tetrahydrofuran. At 0, 833 (L2 molar solution of vinylmagnesium chloride in tetrahydrofuran @1〇 m〇i Grignard reagent) was added dropwise over 1 hour and the mixture was then stirred for a few hours under the arm. For the treatment, the mixture was added dropwise to a 21% aqueous solution of half-saturated ammonium chloride over 3 minutes at 〇 to +5t:. Subsequently, 2 1 methyl tertiary butyl ether was injected with sufficient stirring. The lower aqueous phase was separated and extracted twice with 5 〇〇. The combined organic phases were washed once with a solution of a half-saturated cesium chloride solution and washed with water, dried over sodium sulfate and concentrated on a rotary evaporator at <RTIgt; The evaporation residue was then dried at +50 C as low as 5 mbar to give 671 g of HpLC. It corresponds to a yield of 98% of the theoretical value. The crude product can be processed without further purification. Example 3 - Synthetic 乂111-&(^15-scale salt: 121668.doc -19- 200811094

將67·〇 g來自實例2之式VI之粗Ci5·,(84·7% ; =〇·245 mol)懸浮於5〇〇 ml二氯甲烷中。在〇〇c下,經1小時注入 84·0 g(〇.245 m〇l)三苯基膦氫溴酸鹽於48〇 ml二氯甲烷中 之溶液。將混合物接著在〇它下攪拌3〇分鐘;隨後,蒸餾 出溶劑,同時引入:1250 ml乙腈,轉移溫度高達+8〇cc。將 所得懸浮液冷卻至0它,在〇艺下充分攪拌丨小時且過濾。 將濾餅用少量冷乙腈洗滌且在+5〇。〔:/2〇毫巴下乾燥。67·〇 g The crude Ci5· from the formula VI of Example 2, (84·7%; =〇·245 mol) was suspended in 5 μl of dichloromethane. Under 〇〇c, a solution of 84·0 g (〇.245 m〇l) of triphenylphosphine hydrobromide in 48 mL of dichloromethane was injected over 1 hour. The mixture was then stirred under hydrazine for 3 Torr; then, the solvent was distilled off while introducing: 1250 ml of acetonitrile at a transfer temperature of up to +8 cc. The resulting suspension was cooled to 0, stirred well under hydrazine and filtered. The filter cake was washed with a small amount of cold acetonitrile and at +5 Torr. [: 2 〇 mbar dry.

最終重ϊ · 73.9g式Vlll-a之C!”鱗鹽(理論值之54·2%) M.p. : 235.5-236〇C HPLC純度:96.8% 將濾液在旋轉蒸發器上濃縮且溶解於12〇…二氯甲烷 中。將溶劑在常壓下蒸餾出’同時引入23〇 ml乙腈,轉移 溫度高達+8〇°C。交換溶劑後,將混合物回流20小時,冷 卻至CTC且在代下充分㈣!小時。過濾出結晶產物,將 其用少量冷乙腈洗滌且在+5{rc/20毫巴下乾燥。 弟一結晶產物之最終重量·· 1 7 6 / m ^ 取、至里Α/·6 g(理論值之12·9〇/0) Μ·ρ· : 234-235〇C HPLC純度:95.5% 91.5 g(理論值之67.1%) 尼爾瑞廷: 式Vlll-aiC!5-鎮鹽之總體產量·· 實例4-合成式I之3,3’-二羥基異瑞 121668.doc -20 - 200811094Final weight · 73.9g of Vlll-a C!” scale salt (54.2% of theory) Mp : 235.5-236〇C HPLC purity: 96.8% The filtrate was concentrated on a rotary evaporator and dissolved in 12〇 In dichloromethane, the solvent was distilled off under normal pressure' while introducing 23 〇ml of acetonitrile, and the transfer temperature was as high as +8 ° C. After exchanging the solvent, the mixture was refluxed for 20 hours, cooled to CTC and fully submerged (4) The hourly product was filtered off, washed with a small amount of cold acetonitrile and dried at +5{rc/20 mbar. The final weight of the crystallization product of the younger one·························· 6 g (12.9〇/0 of theory) Μ·ρ· : 234-235〇C HPLC purity: 95.5% 91.5 g (67.1% of theory) Nieling: Formula Vlll-aiC!5- town Overall yield of salt·· Example 4 - Synthesis of formula I 3,3'-dihydroxyisosole 121668.doc -20 - 200811094

將133.7 g(0.24 mol)根據實例3製備之式Vlll-a之C15-鎮 鹽、16·4 g(〇」〇 m〇l)式 IX 之 2,7-二甲基辛·2,4,6-三烯二 酸、500 ml乙醇及150 ml 1,2-環氧丁烷之混合物回流20小 ,時。將懸浮液隨後冷卻至0°c且在〇°c下充分攪拌1小時。 濾出結晶產物且將其在+ 5 0°C /2 0毫巴下乾燥。 • 最終重量:38·4 g式1之3,3匕二羥基異瑞尼爾瑞廷(理論 值之68.6%,以式IX之二醛計) M.p. : 218-221〇C HPLC純度:97·60/〇 為超純化’將產物懸浮於700 ml四氫吱喃中。將懸浮液 回流3 0分鐘且趁熱藉由過濾澄清。在常壓下,經蒸餾橋自 濾液中蒸餾出600 ml溶劑;經15分鐘,將350⑷乙腈逐滴 添加至熱底部產物中。將所得晶體懸浮液回流丨5分鐘,冷 _ 卻至〇°C且在〇°〇下充分攪拌1小時。伴以抽吸濾出結晶產 物且將其在至多+50°C/20毫巴下乾燥。 、 最終重量:35·1 g式1之產物(理論值之91.4%,以第一結 晶產物計) M.p. : 228-230〇C HPLC純度:98·6% E^CHCU):在 465 nm 下為 2166 121668.doc -21 -133.7 g (0.24 mol) of C15-salt salt of formula Vlll-a prepared according to Example 3, 16.4 g (〇"〇m〇l) of 2,7-dimethyloctyl 2,4 of formula IX, A mixture of 6-trienedioic acid, 500 ml of ethanol and 150 ml of 1,2-butylene oxide was refluxed for 20 hours. The suspension was subsequently cooled to 0 ° C and stirred well for 1 hour at 〇 ° c. The crystalline product was filtered off and dried at +50 ° C /2 0 mbar. • Final weight: 3·4 g of formula 1 of 3, 3 匕 dihydroxyiso-niramidine (68.6% of theory, based on aldehyde of formula IX) Mp : 218-221〇C HPLC purity: 97· 60/〇 was ultra-purified' and the product was suspended in 700 ml of tetrahydrofuran. The suspension was refluxed for 30 minutes and clarified by filtration while hot. Under normal pressure, 600 ml of solvent was distilled from the filtrate through a distillation bridge; 350 (4) acetonitrile was added dropwise to the hot bottom product over 15 minutes. The resulting crystal suspension was refluxed for 5 minutes, cooled to 〇 ° C and stirred well for 1 hour under 〇 °. The crystalline product was filtered off with suction and dried at up to +50 ° C / 20 mbar. , final weight: 35·1 g of product of formula 1 (91.4% of theory, based on the first crystalline product) Mp: 228-230〇C HPLC purity: 98·6% E^CHCU): at 465 nm 2166 121668.doc -21 -

Claims (1)

200811094 十、申請專利範圍: 1. 一種製備式I之3,3’-二羥基異瑞尼爾瑞廷(3,3’-dihydroxyisorenieratin)之方法:200811094 X. Patent application scope: 1. A method for preparing 3,3'-dihydroxyisoreneieratin of formula I: 該方法包含至少一個以下步驟: a)使式11之€1()-醛: Η IThe method comprises at least one of the following steps: a) making the formula 1 of the formula 1 aldehyde: Η I 與代表式Ilia之結構單元之等效物的化合物反應: Ilia Η , 其置換式11之0:1()-醛之羰基氧原子以產生式IViC13-酮:Reaction with a compound representing the equivalent of the structural unit of formula Ilia: Ilia Η , which replaces the carbonyl oxygen atom of the formula 11 with 0:1 ()-aldehyde to give the formula IViC13-ketone: b)使式IV之Ci3-酮與式Va之乙烯系化合物反應: Va , 121668.doc 200811094 或 使式IV2C13-酮與式Vb之乙炔系化合物反應: =—-M1 Vb , 接著使參鍵部分氫化以產生式VI之c15-醇:b) reacting a Ci3-ketone of the formula IV with a vinyl compound of the formula Va: Va, 121668.doc 200811094 or reacting a ketone of the formula IV2C13-ketone with an acetylene compound of the formula Vb: =--M1 Vb, followed by a key moiety Hydrogenation to produce c15-alcohol of formula VI: 其中 M1 為 Li、Na、K、MgCl、MgBr、Mgl 或 Mg1/2, c)使式VI之C15-醇與強有機或無機酸HX反應,其中X 為該酸HX之陰離子,以產生式VII之C15-結構單元:Wherein M1 is Li, Na, K, MgCl, MgBr, Mgl or Mg1/2, c) reacting a C15-alcohol of formula VI with a strong organic or inorganic acid HX, wherein X is an anion of the acid HX to yield formula VII C15-structural unit: 接著使式VII之C15結構單元與三芳基膦P(芳基)3反應 以產生式VIIIiC15-鱗鹽: p+(芳基)3χ·The C15 structural unit of formula VII is then reacted with a triarylphosphine P(aryl)3 to yield a VIIIiC15-square salt: p+(aryl)3χ· HO VIII 或 使式VI2C15-醇與式P(芳基)3·ΗΧ之三芳基膦/HX加 合物反應以產生式VIII之C15-鱗鹽, 121668.doc 200811094HO VIII or reacting an alcohol of formula VI2C15- with a triarylphosphine/HX adduct of formula P(aryl)3·ΗΧ to yield a C15-square salt of formula VIII, 121668.doc 200811094 以產生式I之化合物。 2.如請求们之方法,其中執行步_、b)、^d)。 月求項1或2之方法’其中在方法步驟a)中,使式„之 C】〇-酸在無需引入酚性〇liA園 H基團之保濩基之情況下轉化為 式 IV<c13-酮。 4·如請求項1至3中任-項之方法,其中在方法步驟a)中, 该代表式心之結構單元之#效物的化合 亞磷烷基>2-丙烷。 本基 5·如請求項1至4中任-項之方法,其中在方法步驟b)中, 使式iV之Cl3·酮與乙烯基氯化鎂反應。 6. 如請求項!至5中任一項之方法’其中方法步驟幻中所使 用使式M C15-醇轉化為式VII之Ch結構單元的強酉随 為氫溴酸或鹽酸。 7. 如請求項⑴中任—項之方法,其中在方法步驟C)中, 使式VkCl5-醇以三苯基膦氫漠酸鹽或三苯基膦鹽酸鹽 直接轉化為式vm之c〗5_鱗鹽,其中芳基為苯基且 或 CM。 · 8· 一種酮,其具有式IV ·· 121668.doc 200811094To produce a compound of formula I. 2. As requested by the method, where steps _, b), ^d) are performed. In the method of claim 1 or 2, wherein in the method step a), the 〇-acid of the formula C is converted to the formula IV <c13 without introducing a thiol group of the phenolic 〇liA garden H group The method of any one of claims 1 to 3, wherein in the method step a), the compound of the structural unit of the representative core is a compound of a phosphorous alkyl group > 2-propane. The method of any one of claims 1 to 4, wherein in the method step b), the Cl3·ketone of the formula iV is reacted with the vinylmagnesium chloride. 6. According to any one of the claims! The method of the method wherein the method for the conversion of the formula M C15-alcohol to the structure of the Ch structural unit of the formula VII is followed by hydrobromic acid or hydrochloric acid. 7. The method according to any one of the items (1), wherein In step C), the VkCl5-alcohol is converted directly as triphenylphosphine hydrochloride or triphenylphosphine hydrochloride to the c-fibrate salt of formula vm wherein the aryl group is phenyl and or CM. · 8· A ketone having the formula IV ·· 121668.doc 200811094 其中 X為強有機或無機酸HX之陰離子。 11. 一種C15-鐫鹽,其具有式VIII :Wherein X is an anion of a strong organic or inorganic acid HX. 11. A C15-onium salt having the formula VIII: 其中 芳基為芳基基團,較佳為苯基,且 X為強有機或無機酸HX之陰離子,較佳為C1或Br。 121668.doc 200811094 七、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: _ 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式:Wherein the aryl group is an aryl group, preferably a phenyl group, and X is an anion of a strong organic or inorganic acid HX, preferably C1 or Br. 121668.doc 200811094 VII. Designated representative map: (1) The representative representative of the case is: (none) (2) The symbol of the symbol of the representative figure is simple: _ VIII. If there is a chemical formula in this case, please reveal the characteristics that can best show the invention. Chemical formula: 121668.doc121668.doc
TW96124528A 2006-07-07 2007-07-05 Process and novel intermediates for the preparation of 3,3'-dihydroxyisorenieratine TW200811094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06116816 2006-07-07

Publications (1)

Publication Number Publication Date
TW200811094A true TW200811094A (en) 2008-03-01

Family

ID=38556329

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96124528A TW200811094A (en) 2006-07-07 2007-07-05 Process and novel intermediates for the preparation of 3,3'-dihydroxyisorenieratine

Country Status (2)

Country Link
TW (1) TW200811094A (en)
WO (1) WO2008003742A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114105737A (en) * 2021-11-24 2022-03-01 重庆华邦胜凯制药有限公司 Preparation method and application of intermediate of abamectin A

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6613365A (en) * 1965-10-07 1967-04-10
DE19723480A1 (en) * 1997-06-04 1998-12-10 Basf Ag Process for the preparation of zeaxanthin, intermediates for this process and process for its preparation
WO2007090095A2 (en) * 2006-01-27 2007-08-09 Cardax Pharmaceuticals, Inc. Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114105737A (en) * 2021-11-24 2022-03-01 重庆华邦胜凯制药有限公司 Preparation method and application of intermediate of abamectin A
CN114105737B (en) * 2021-11-24 2024-08-02 重庆华邦胜凯制药有限公司 Preparation method and application of intermediate of abamectin

Also Published As

Publication number Publication date
WO2008003742A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
US6689912B2 (en) Methods for preparing O-desmethylvenlafaxine
KR101454571B1 (en) Synthesis of intermediate for treprostinil production
JP4287546B2 (en) Manufacturing method of glyceryl ether
JP5481712B2 (en) Production of γ, δ-unsaturated ketones
CN106414375B (en) In compound or associated improvement
CN108727170B (en) 1-halo-6, 9-pentadecadienes and process for preparing (7Z,10Z) -7, 10-hexadecadienals
US9108912B2 (en) Hydroformylation process
CA3174197A1 (en) Catalytic cannabigerol processes and precursors
US9809524B1 (en) Process for the preparation of 1-(3,5-dichloro-4-fluoro-phenyl)-2,2,2-trifluoro-ethanone
TW200811094A (en) Process and novel intermediates for the preparation of 3,3'-dihydroxyisorenieratine
EP2639217B1 (en) Methods for preparing 5-Acetoxy-(E3)-3-pentenyl methoxymethyl ether and an (E3)-3-alkenyl acetate
CN109956850B (en) Process for producing 3, 7-dimethyl-7-octenyl alcohol and 3, 7-dimethyl-7-octenyl carboxylate compound
JP2001072636A (en) Production polyol alkyl ether
TWI229664B (en) A process for preparing 2,7-dimethyl-2,4,6-octatrienal monoacetals
KR100541786B1 (en) A method for preparing alcohols by using (3-alkoxyphenyl)magnesium chlorides
US20100069664A1 (en) Method for preparing (e3,z5)-3,5-alkadienyl acetate
US11370738B2 (en) Process for the production of 2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal
JP5448572B2 (en) Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound
US10570072B2 (en) Process for the preparation of alcohols from alfa, beta-unsaturated aldehydes and ketones
CN101516841B (en) Improved method of production of 9-cis-retinoic acid
JP2005306865A (en) Cis- and trans-stilbene compounds each containing boric acid group and their preparation methods
EP2621883B1 (en) Improved synthesis of peretinoin
JP2002069026A (en) Method for manufacturing (e)-3-methyl-2- cyclopentadecenone
US10807941B2 (en) Process for the preparation of polysantol-type compounds
JP2023102593A (en) Method for producing 2-substituted 1,3-propanediol